DHC Fundamental Analysis - DIVERSIFIED HEALTHCARE TRUST

Fundamental Rating

DHC gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 129 industry peers in the Diversified REITs industry. DHC may be in some trouble as it scores bad on both profitability and health. DHC does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year DHC has reported negative net income.

In the past year DHC had a positive cash flow from operations.

In the past 5 years DHC reported 4 times negative net income.

In multiple years DHC reported negative operating cash flow during the last 5 years.

1.2 Ratios

DHC has a Return On Assets of -6.03%. This is amonst the worse of the industry: DHC underperforms 84.50% of its industry peers.

With a Return On Equity value of -15.46%, DHC is not doing good in the industry: 78.29% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-6.03%
ROE	-15.46%
ROIC	N/A

ROA(3y)-4.29%

ROA(5y)-2.48%

ROE(3y)-10.69%

ROE(5y)-6.22%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

DHC's Gross Margin of 17.80% is on the low side compared to the rest of the industry. DHC is outperformed by 93.02% of its industry peers.

DHC's Gross Margin has declined in the last couple of years.

DHC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	17.8%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-6.33%

GM growth 5Y-20.05%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

DHC does not have a ROIC to compare to the WACC, probably because it is not profitable.

DHC has more shares outstanding than it did 1 year ago.

The number of shares outstanding for DHC has been increased compared to 5 years ago.

The debt/assets ratio for DHC is higher compared to a year ago.

2.2 Solvency

DHC has an Altman-Z score of -0.31. This is a bad value and indicates that DHC is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of -0.31, DHC is doing worse than 80.62% of the companies in the same industry.

DHC has a Debt/Equity ratio of 1.42. This is a high value indicating a heavy dependency on external financing.

DHC has a Debt to Equity ratio of 1.42. This is comparable to the rest of the industry: DHC outperforms 43.41% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	1.42
Debt/FCF	N/A
Altman-Z	-0.31

ROIC/WACCN/A

WACC6.47%

2.3 Liquidity

DHC has a Current Ratio of 3.37. This indicates that DHC is financially healthy and has no problem in meeting its short term obligations.

DHC has a better Current ratio (3.37) than 93.02% of its industry peers.

DHC has a Quick Ratio of 3.37. This indicates that DHC is financially healthy and has no problem in meeting its short term obligations.

The Quick ratio of DHC (3.37) is better than 93.02% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.37
Quick Ratio	3.37

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.64% over the past year.

The Revenue has been growing slightly by 4.29% in the past year.

DHC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.53% yearly.

EPS 1Y (TTM)39.64%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-8.57%

Revenue 1Y (TTM)4.29%

Revenue growth 3Y2.63%

Revenue growth 5Y7.53%

Sales Q2Q%3.05%

3.2 Future

Based on estimates for the next years, DHC will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.22% on average per year.

The Revenue is expected to grow by 3.57% on average over the next years.

EPS Next Y28.82%

EPS Next 2Y16.22%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year3.93%

Revenue Next 2Y3.57%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DHC. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DHC. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

DHC's Enterprise Value to EBITDA is on the same level as the industry average.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	14.33

4.3 Compensation for Growth

A more expensive valuation may be justified as DHC's earnings are expected to grow with 16.22% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y16.22%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

DHC has a Yearly Dividend Yield of 1.12%. Purely for dividend investing, there may be better candidates out there.

With a Dividend Yield of 1.12, DHC pays less dividend than the industry average, which is at 6.31. 93.02% of the companies listed in the same industry pay a better dividend than DHC!

Compared to an average S&P500 Dividend Yield of 2.34, DHC's dividend is way lower than the S&P500 average.

		Industry Rank	Sector Rank
Dividend Yield	1.12%

5.2 History

The dividend of DHC decreases each year by -45.60%.

DHC has been paying a dividend for at least 10 years, so it has a reliable track record.

DHC has not decreased its dividend in the last 3 years.

Dividend Growth(5Y)-45.6%

Div Incr Years0

Div Non Decr Years3

5.3 Sustainability

The earnings of DHC are negative and hence is the payout ratio. DHC will probably not be able to sustain this dividend level.

DP-3.36%

EPS Next 2Y16.22%

EPS Next 3YN/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

DIVERSIFIED HEALTHCARE TRUST

NASDAQ:DHC (8/28/2025, 12:16:03 PM)

3.675

-0.12 (-3.29%)

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryDiversified REITs

Earnings (Last)08-04 2025-08-04/amc

Earnings (Next)11-03 2025-11-03/amc

Inst Owners77.81%

Inst Owner Change2.01%

Ins Owners0.41%

Ins Owner ChangeN/A

Market Cap887.18M

Analysts48

Price Target3.83 (4.22%)

Short Float %2.31%

Short Ratio5.24

Dividend

		Industry Rank	Sector Rank
Dividend Yield	1.12%

Yearly Dividend0.04

Dividend Growth(5Y)-45.6%

DP-3.36%

Div Incr Years0

Div Non Decr Years3

Ex-Date07-21 2025-07-21 (0.01)

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)25.74%

Min EPS beat(2)-71.02%

Max EPS beat(2)122.5%

EPS beat(4)2

Avg EPS beat(4)34.05%

Min EPS beat(4)-71.02%

Max EPS beat(4)122.5%

EPS beat(8)3

Avg EPS beat(8)16.12%

EPS beat(12)4

Avg EPS beat(12)5.38%

EPS beat(16)4

Avg EPS beat(16)-11.59%

Revenue beat(2)0

Avg Revenue beat(2)-0.26%

Min Revenue beat(2)-0.49%

Max Revenue beat(2)-0.04%

Revenue beat(4)1

Avg Revenue beat(4)-0.41%

Min Revenue beat(4)-2.43%

Max Revenue beat(4)1.32%

Revenue beat(8)2

Avg Revenue beat(8)-0.47%

Revenue beat(12)4

Avg Revenue beat(12)-0.38%

Revenue beat(16)4

Avg Revenue beat(16)-1.01%

PT rev (1m)0%

PT rev (3m)15.38%

EPS NQ rev (1m)-2.5%

EPS NQ rev (3m)6.82%

EPS NY rev (1m)-14.73%

EPS NY rev (3m)-19.35%

Revenue NQ rev (1m)0.97%

Revenue NQ rev (3m)-2.81%

Revenue NY rev (1m)0.32%

Revenue NY rev (3m)-0.89%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.58
P/FCF	N/A
P/OCF	9.96
P/B	0.48
P/tB	0.48
EV/EBITDA	14.33

EPS(TTM)-0.67

EYN/A

EPS(NY)-0.68

Fwd EYN/A

FCF(TTM)-0.41

FCFYN/A

OCF(TTM)0.37

OCFY10.04%

SpS6.31

BVpS7.68

TBVpS7.68

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-6.03%
ROE	-15.46%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	17.8%
FCFM	N/A

ROA(3y)-4.29%

ROA(5y)-2.48%

ROE(3y)-10.69%

ROE(5y)-6.22%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-6.33%

GM growth 5Y-20.05%

F-Score6

Asset Turnover0.32

Health

		Industry Rank	Sector Rank
Debt/Equity	1.42
Debt/FCF	N/A
Debt/EBITDA	11.07
Cap/Depr	66.82%
Cap/Sales	12.33%
Interest Coverage	N/A
Cash Conversion	37.41%
Profit Quality	N/A
Current Ratio	3.37
Quick Ratio	3.37
Altman-Z	-0.31

F-Score6

WACC6.47%

ROIC/WACCN/A

Cap/Depr(3y)103.34%

Cap/Depr(5y)92.72%

Cap/Sales(3y)19.78%

Cap/Sales(5y)17.46%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)39.64%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-8.57%

EPS Next Y28.82%

EPS Next 2Y16.22%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)4.29%

Revenue growth 3Y2.63%

Revenue growth 5Y7.53%

Sales Q2Q%3.05%

Revenue Next Year3.93%

Revenue Next 2Y3.57%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y38.29%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year374.57%

EBIT Next 3Y72.02%

EBIT Next 5YN/A

FCF growth 1Y71.19%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y283.65%

OCF growth 3YN/A

OCF growth 5Y-15.84%

DIVERSIFIED HEALTHCARE TRUST (DHC) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

5.2 History

5.3 Sustainability

More info and screens